On 6 June 2017, the World Health Organization (WHO) published updates to its ‘Essential Medicines List’ (EML). Read more here.

Extended deadline (from 1 July to 31 July) 2017 for call to submit papers on effectiveness and cost-effectiveness of screening and prevention of infectious diseases among newly arrived migrants in Europe. Read more here.

Eurosurveillance is on the updated list of the Directory of Open Access Journals and in the SHERPA/RoMEO database. Read more here.

Follow Eurosurveillance on Twitter: @Eurosurveillanc

In this issue

Home Eurosurveillance Monthly Release  2003: Volume 8/ Issue 10 Article 1
Back to Table of Contents
en es fr

Eurosurveillance, Volume 8, Issue 10, 01 October 2003
Conference report
Seventh International Meeting of the European Laboratory Working Group on Diphtheria - Vienna, June 2002

Citation style for this article: Kelly C, Efstratiou A. Seventh International Meeting of the European Laboratory Working Group on Diphtheria - Vienna, June 2002. Euro Surveill. 2003;8(10):pii=427. Available online:


C Kelly, A Efstratiou on behaff of DIPNET: European Diphtheria Surveillance Network and the European Laboratory Working Group on Diphtheria, Respiratory and Systemic Infection Laboratory, Specialist and Reference Microbiology Division, Health Protection Agency, United Kingdom


The Seventh International Meeting of the European Laboratory Working Group on Diphtheria (ELWGD) was held in Vienna, Austria in June 2002 and brought together the microbiologists and epidemiologists responsible for diphtheria in many countries throughout the world. The ELWGD was formed in 1993 in response to the epidemics of diphtheria in Russia and the Newly Independent States (NIS) of the former Soviet Union (1,2). These epidemics, and others elsewhere, highlighted the importance of strengthening and maintaining both epidemiological surveillance and reliable laboratory screening. Since December 2001, these areas have been progressed and strengthened by European Commission (EC) funding to undertake a feasibility study for diphtheria surveillance amongst European Union (EU) member states and accession countries, and to establish a definitive and official European diphtheria surveillance network called DIPNET (EC DG SANCO Agreement No. S12.324473 (2001 CVG4-012)). This was the first international meeting of the ELWGD to be organised and funded under the auspice of the DIPNET (European Diphtheria Surveillance Network).
DIPNET will continue a collaborative and coordinated approach to support countries to improve diphtheria surveillance for early detection of cases and contacts by accurate microbiological and epidemiological surveillance (3,4,5). The network of national and international laboratories includes,
not only microbiologists, but also epidemiologists from most of the EU member states and accession countries. Communication between laboratories and public health authorities within and between countries enhances the capacity of an EU member state to respond rapidly to this public health threat (6).
Participants in this meeting came from 39 different countries including 12 EU member states, six accession countries, 12 NIS countries, and Brazil, Canada, India, Israel, Norway, Switzerland, Turkey, and the United States (US). This report summarises the presentations given at this meeting which provided an interesting overview of the surveillance of diphtheria within the Russian Federation and NIS as well as the EU member states and accession countries, a review of the clinical and microbiological aspects of infection caused by corynebacteria, and an update on recent studies on the molecular and genetic characteristics of Corynebacterium diphtheriae and C. ulcerans.

Microbiological surveillance of diphtheria in the NIS of the former Soviet Union
The recent epidemic of diphtheria in the NIS began in the Russian Federation in 1990 and affected all 12 NIS by the end of 1994 (7). In 1990, the number of reported diphtheria cases in the NIS was 1 436. However, in 1993 the number of cases dramatically increased to 19 604, then to 47 869 in 1994, and finally reached a peak of 50 434 in 1995. The prominent strains during this epidemic were C. diphtheriae var gravis ribotypes Sankt-Petersburg and Rossija. At the beginning of the epidemic, the case fatality rate was very high and was probably due to inadequate supplies of antitoxin, improper case management, and delayed treatment. Diphtheria control efforts, coordinated by the World Health Organization (WHO), began in the Russian Federation in 1992 and included mass immunisation campaigns which covered most of the adult population (8). Further control efforts and mass immunization campaigns in the other NIS followed. In recent years, the number of cases reported to the European Region of WHO have fallen to approximately 1 500 in 1999 and 2000.
Excellent progress has been achieved in the control of diphtheria in Armenia, Azerbaijan, Belarus, Estonia, Kazakhstan, Lithuania, Republic of Moldova, Turkmenistan, and Uzbekistan, where the incidence of the disease has reached low levels. However, the number of cases are higher in Georgia, Kyrghyzstan, Latvia, the Russian Federation, Tajikistan and the Ukraine (9,10). Some regions appear to have higher incidence rates than others: during recent years, for example, there has been an increase in the number of diphtheria cases reported in the Smolensk region of the Russian Federation. In 2001, 30 cases were reported in Smolensk, giving an incidence of 2.66 per 100 000 population, while the incidence in the Russian Federation as a whole was only 0.57 per 100 000 population. Seventy three per cent of the cases were adults, and two adult patients died. A dramatic increase in carriage rates of toxigenic C. diphtheriae strains was also observed. When there is an increase in the incidence of diphtheria, additional anti-epidemic measures may be needed to increase the coverage rates in all age groups.

Beginning in 1998, an annual increase of diphtheria incidence was also observed in the St Petersburg region, with an incidence of 2.6 per 100 000, mainly in adult patients. Since 2000, most of the diphtheria cases have been caused by toxigenic C. diphtheriae var mitis ribotype Otchakov. Screening and serological investigations amongst different social and professional risk groups have recently been performed in this region. A total of 472 sera from individuals aged between 20 to 69 years were studied, and 35% were susceptible to diphtheria. Fifty two per cent of individuals aged between 40 and 59 years had only ever been given one booster vaccination. Among those who had been given two boosters, the proportion of susceptibles was only 25%. For effective control of the epidemic in this district, immunisation of adults with two boosters may be required. Immunisation of the booster vaccine to the adult population has begun in this region, but it seems that ribotype Otchakov may present a new public health threat in the future.

Epidemiology of diphtheria in EU member states and accession countries
Although the risk of resurgence of diphtheria in EU member state countries is relatively low, the capacity to control and prevent diphtheria must be maintained due to close links with other higher incidence countries. The ability to recognise an imported case of diphtheria rapidly and to control any potential spread of the disease within the community is a public health priority (3). Laboratory facilities, clinical expertise, and surveillance all need to be maintained. Additionally, travellers to countries where the disease is endemic need to be protected, so adequate supplies of antitoxin and toxoid vaccine must be available when required.
Many of the EU member states and accession countries see either no cases or very few cases of diphtheria each year. However, the WHO Collaborating Centre for Diphtheria at the Respiratory and Systemic Infection Laboratory of the Health Protection Agency in the United Kingdom (UK) identified 36 isolates of toxigenic corynebacteria between the beginning of 1997 and the end of 2002 from throat swabs and other samples types referred for toxigenicity testing, 58% (21/36) of which were identified as C. ulcerans. Infection with C. ulcerans in humans is 'traditionally' associated with consumption of raw dairy products or contact with farm animals; however, no such risk factors were identified for about half of the cases.

In April 1993, the first imported case of diphtheria for nearly thirty years was identified in Finland and was found to be caused by toxigenic C. diphtheriae var gravis. Since then, a total of fifteen isolations of C. diphtheriae have been reported, the majority produced toxin (13/15) and were var gravis (10/15). Twelve of the cases had epidemiological links to Russia and were caused by toxigenic C. diphtheriae. Based on ribotype analysis, most of the var gravis isolates were indistinguishable from the the Russian epidemic clone group Sankt-Peterburg/Rossija (11,12). Despite extensive traffic across the border, the small number of diphtheria cases identified in Finland in recent years suggests that the overall immunity of the population is relatively good (13).
During 2002, the first case of diphtheria since 1989 was identified in France in a female Chinese immigrant who presented with dysphasia and fever. She had lived in France for the last two years and was probably unimmunised. Toxigenic C. diphtheriae var mitis was isolated from a throat swab taken from this patient which revealed a new ribotype pattern Lariboisière. Also in 2002, the first case of diphtheria in Italy since 1998 was seen in a 14 year old boy from Friuli, northern Italy, who presented with fever, sore throat, lymphadenopathy and pseudomembrane. Toxigenic C. ulcerans was isolated from a throat swab, but the source of the infection was not ascertained.

Currently, Latvia has the highest incidence rate of diphtheria of any of the EU member states or accession countries. Between September 1993 and 2001, 1 288 cases of diphtheria were reported, including 96 deaths. Diphtheria incidence has peaked twice during this period, first between
1994 and 1996 and then between 1999 and the present time. During the first peak, more than 71% diphtheria cases were reported amongst adults, most of whom were unvaccinated, and especially high morbidity levels was seen in those aged between 30 and 59 years (14). This is consistent with the usual epidemiology of the disease in a population that has high levels of childhood vaccination, but incomplete adult coverage. During the last increase in incidence, however, the proportion aged between 30 and 59 years decreased by 19%, and 97% had been vaccinated against diphtheria in childhood. The reasons for this last resurgence are still not completely understood.

Clinical and microbiological aspects of infection caused by potentially toxigenic and other corynebacteria
A large seroepidemiological study of 558 injured patients aged between 18 and 70 years was conducted at an outpatient clinic of a trauma department in Vienna, Austria. Twenty seven per cent of the subjects were susceptible to diphtheria, 27% had basic protection, and 46% were fully protected (15). Multiple linear regression analysis revealed that age and gender both had a significant independent influence on diphtheria immunity level. In another study carried out in northern Greece on sera from 429 healthy children and adults aged between 0 and 80 years, immunity rates against diphtheria were found to be protective in high proportions of individuals up to 20 years of age, after which time immunity levels declined sharply. Another seroepidemiological study in Slovenia also showed a high level of protective immunity in children and young adults and, again, there was evidence of a fall in the level of protective antibodies in adults.

Between 1998 and 2000, antibiotic susceptibility tests were carried out on 148 isolates of C. diphtheriae from diphtheria patients and carriers in the Moscow, Murmansk, Omsk, Kaliningrad, Vladimir and Krasnodar regions of Russia. Sixteen of these isolates (11%), all of which had been characterised as the epidemic clonal group of toxigenic C. diphtheriae var gravis ribotype Sankt-Peterburg/Rossija, were found to be resistant to macrolide and lincosamide antibiotics such as erythromycin, azythromycin, lincomycin, and clindamycin (11). No antibiotic-resistant strains were found among isolates that circulated in Russia between the early 1980s and 1998.
The completion of the genome sequence of C. diphtheriae offers new strategies for studying host-pathogen interactions. An investigation was described that was recently undertaken in Brazil to examine the interactions leading up to and involving the adherence process of C. diphtheriae to human epithelial cells, the primary step made in the colonisation and invasion of the host (16,17). Thirteen strains were tested and displayed varying degrees of attachment to HEp-2 cell monolayers with two distinct adherence patterns: the predominant type called localised (LA), and diffuse (DA) (18). The LA pattern was mainly observed among the glass adherent/sucrose fermenting strains (19). Bacterial adherence to HEp-2 cells was inhibited in varied degrees by carbohydrate moieties. Initial indications point to these carbohydrate components as putative adhesins of C. diphtheriae to human epithelial cells.

Molecular and genetic characteristics of corynebacteria
Ribotyping, a universal molecular typing method for bacteria based upon rRNA gene restriction pattern determination, has previously been recognised as the best marker for the molecular typing of C. diphtheriae isolates. The endonucleases chosen for the standard methodology were BstEII (first choice) and PvuII (second choice), because when these enzymes are used, ribotypes often share common bands, which make pattern comparison easier. International exchange of typing data can be carried out and there is now a database of all C. diphtheriae ribotypes with a standard ribotype nomenclature to facilitate communication between laboratories. The recommended software for interpretation of C. diphtheriae ribotypes is Taxotron 2000® (Taxolab, Institut Pasteur, Paris, France) for interpolation of fragment sizes (20). To date, 86 distinct ribotypes with the endonuclease BstEII have been chosen for the ribotype database, and each ribotype pattern has been represented by a reference strain possessing a unique geographical name, producing a stable and reproducible ribotype pattern (21). These strains have now also been submitted to automated ribotyping using the RiboPrinter® Microbial Characterization System (Qualicon, Wilmington, DE, USA) using both endonucleases (22). Identification and verification of new and existing genetically defined clones of C. diphtheriae with the potential to cause epidemics can be made.
In 2002, a toxigenic strain of C. diphtheriae var mitis was isolated from a throat swab of a boy aged 11 years from a religious community in Salford, north west England (23). A toxigenic strain of C. diphtheriae var mitis was also isolated from a family member aged 3 years in Jerusalem and the two isolates were found to be indistinguishable from their ribotype patterns. This is an excellent example of how ribotyping can be used in 'tracking' the international spread of this disease. Disease transmission does not necessarily occur as an isolated event in one country but may have implications for spread to other countries (3).

In Belarus, the majority of toxigenic strains in the last few years have been biotype var gravis and their ribotypes were mainly Sankt-Petersburg, Rossija, and Lyon ribotypes. Many of the strains circulating in Belarus, however, have been non-toxigenic tox-bearing (NTTB) strains of C. diphtheriae var mitis that are phenotypically non-toxigenic but carry the tox-gene, and these have been mainly represented by the ribotype Moskva, while the other non-toxigenic strains were mainly ribotype Cluj (11,21). Ribotyping has successfully been used for molecular subtyping and the identification and monitoring of clonal groups (24).
As previously mentioned, human infection with C. ulcerans is usually acquired through contact with animals or by ingestion of unpasteurised dairy products, although risk factors are often undetermined (3). In the UK, the frequency and severity of C. ulcerans infections appear to be increasing. Between 1986 and 2001 a total of 51 C. ulcerans isolates, 84% of which were toxigenic strains, were identified. Ribotyping results of toxigenic C. ulcerans isolated from three cats with bilateral nasal discharge have shown that the profiles produced are so far indistinguishable from human isolates (25). The isolation of toxigenic C. ulcerans from domestic cats, in addition to the possibility of person to person spread, highlights the importance of further research into the role of C. ulcerans in the epidemiology of diphtheria (15).

The complete genome of the C. diphtheriae NCTC 13129 strain, an isolate of the epidemic clone (ribotype Sankt-Petersburg), circulating within eastern Europe during the 1990s, has been sequenced at the Pathogen Sequencing Unit at the Sanger Institute. A whole-genome shotgun technique was used and the final sequence was assembled from 66 099 sequencing reads. Analysis of the sequence was carried out using the software tool Artemis and the Artemis Comparison Tool (ACT) was also used to compare this genome with other bacterial genomes, both at the DNA or protein level. The genome sequence data is available at

The completion of this genome sequence has enabled the development of further studies into the molecular and genetic characteristics of corynebacteria. A comprehensive study of NTTB-strains, all of biotype C. diphtheriae var mitis, was recently carried out in Moscow (26,27,28). The lack of diphtheria toxin production by these strains was explained by a mutation a single base deletion at nucleotides 52-55 - that was the result of a frameshift that subsequently produced a loss of the tox-gene open reading frame and the truncation of the tox protein. However, some researchers have discovered toxigenic properties in these NTTB strains and argued that toxin production can be easily restored after passage through dialysis cellophane on iron-deficient Elek media.
At the University of Colorado in the US, an impressive molecular analysis was carried out on the regulation and function of the diphtheria toxin repressor (DtxR) of C. diphtheriae (27). The conclusion to this study was that DtxR represses siderophore biosynthesis more stringently than diphtheria toxin production, and that that DtxR was not essential for the viability of C. diphtheriae, although those strains with mutations within the dtxR gene did exhibit enhanced susceptibility to oxidative stress (29).

Further research and exploration into the genome sequence of C. diphtheriae are providing sources of inspiration and new understanding of the pathogenicity of toxigenic, NTTB, and non-toxigenic strains. The numbers of participants in this international conference highlighted the expansion of this specialised area of microbiology, with attendees several continents. An international surveillance network within Europe is essential for the control of a resurging, potentially fatal, vaccine-preventable infectious disease such as diphtheria. Diphtheria is an excellent example of a situation where public health services are expected to deliver a timely and coordinated response to a public health threat such as an imported case that may originate outside Europe, but which has the potential to spread within that country.

The authors gratefully acknowledge the contribution of all participants of the Seventh International Meeting of the ELWGD, the European Commission (EU DG SANCO Agreement No. S12.324473 (2001 CVG4-012)), the Public Health Laboratory Service, the Department of Traumatology at the University of Vienna, the Federal Ministry of Social Security and Generations in Vienna, the Vienna Medical Academy, the WHO Regional Office for Europe, and the Wellcome Trust.

The Programme and Abstracts Book for the meeting are accessible in pdf format.


1. Efstratiou A, Roure C, members of the European Laboratory Working Group on Diphtheria. The European Laboratory Working Group on Diphtheria: a global microbiologic network. J Infect Dis 2000; 181 (Suppl 1): S146-51. (
2. Lai S, Efstratiou A on behalf of the European Laboratory Working Group on Diphtheria. Report on the Sixth International Meeting of the European Working Group on Diphtheria, Brussels, Belgium. Eurosurveillance 2002; 7: 7-12. (
3. Efstratiou A, Engler KH, Mazurova IK, Glushkevich T, Vuopio-Varkila J, Popovic T. Current approaches to the laboratory diagnosis of diphtheria. J Infect Dis 2000; 181 (Suppl 1): S138-45. (
4. Efstratiou A, George RC. Laboratory guidelines for the diagnosis of infections caused by Corynebacterium diphtheriae and C. ulcerans. World Health Organization. Commun Dis Public Health 1999; 2: 250-7.
5. Engler KH, Kozlov RS, Copping SJ, European Laboratory Working Group on Diphtheria, Efstratiou A. International External Quality Assessment scheme for the laboratory diagnosis of diphtheria. J Med Microbiol 2001; 50: 1006-12.
6. Bonnet JM, Begg NT. Control of diphtheria: guidance for consultants in communicable disease control. Commun Dis Public Health 1999; 2: 242-9. (
7. Popovic T, Kombarova SV, Reeves MW, Nakao H, Mazurova IK, Wharton M, et al. Molecular epidemiology of diphtheria in Russia, 1985-1994. J Infect Dis 1996; 174: 1064-72.
8. Dittmann S, Wharton M, Vitek C, Ciotti M, Galazka A, Guichard S, et al. Successful control of epidemic diphtheria in the states of the Former Union of Soviet Socialist Republics: lessons learned. J Infect Dis 2000; 181 (Suppl 1): S10-22. (
9. Sulakvelidze A, Kekelidze M, Gomelauri T, Deng Y, Khetsuriani N, Kobaidze K, et al. Diphtheria in the Republic of Georgia: use of molecular typing techniques for characterization of Corynebacterium diphtheriae strains. J Clin Microbiol 1999; 37: 3265-70. (
10. Griskevica A, Ching P, Russo G, Kreysler J. Diphtheria in Latvia, 1986-1996. J Infect Dis 2000; 181 (Suppl 1): S60-4. (
11. Popovic T, Mazurova IK, Efstratiou A, Vuopio-Varkila J, Reeves MW, De Zoysa A, et al. Molecular epidemiology of diphtheria. J Infect Dis 2000; 181 (Suppl 1): S168-77.
12. De Zoysa A, Efstratiou A, George RC, Jahkola M, Vuopio-Varkila J, Deshevoi S, et al. Molecular epidemiology of Corynebacterium diphtheriae from northwestern Russia and surrounding countries studied by using ribotyping and pulsed-field gel electrophoresis. J Clin Microbiol 1995; 33: 1080-3. (
13. Lumio J, Ölander RM, Groundstroem K, Suomalainen P, Honkanen T, Vuopio-Varkila J. Epidemiology of three cases of severe diphtheria in Finnish patients with low antitoxin antibody levels.
Eur J Clin Microbiol Infect Dis 2001; 20: 705-10.
14. Rønne T, Valentelis R, Tarum S, Griskevica A, Wachmann CH, Aggerbeck H, et al. Immune response to diphtheria booster vaccine in the Baltic states. J Infect Dis 2000; 181
(Suppl 1): S213-9. (
15. Marlovits S, Stocker R, Efstratiou A, Broughton K, Kaider A, Vécsei V, et al. Effect on diphtheria immunity of combined tetanus and diphtheria booster vaccination of adults. Eur J Clin Microbiol Infect Dis 2000; 19: 506-13.
16. Colombo AV, Hirata R Jr, de Souza CMR, Monteiro-Leal LH, Previato JO, Formiga LCD, et al. Corynebacterium diphtheriae surface proteins as adhesions to human erythrocytes. FEMS Microbiol Lett 2001; 197: 235-9.
17. Hirata R, Napoleão F, Monteiro-Leal LH, Andrade AFB, Nagao PE, Formiga LCD, et al. Intracellular viability of toxigenic Corynebacterium diphtheriae strains in HEp-2 cells. FEMS Microbiol Lett 2002; 215: 115-9.
18. Mattos-Guaraldi AL, Formiga LCD, Pereira GA. Cell surface components and adhesion in Corynebacterium diphtheriae. Microbes Infect 2000; 2: 1507-12.
19. De Mattos-Guaraldi AL, Formiga LCD. Bacteriological properties of a sucrose-fermenting Corynebacterium diphtheriae strain isolated from a case of endocarditis. Curr Microbiol 1998; 37: 156-8.
20. Regnault B, Grimont F, Grimont PAD. Universal ribotyping method using a chemically labelled oligonucleotide probe mixture. Res Microbiol 1997; 148: 649-59.
21. Grimont PAD, Grimont F, Efstratiou A, De Zoysa A, Mazurova I, Lejay-Collin M, et al. International nomenclature for Corynebacterium diphtheriae ribotypes. Res Microbiol (in press).
22. De Cesare A, Manfreda G. Use of the automated ribotyping for epidemiological investigations. Ann Microbiol 2002; 52: 181-90.
23. PHLS. Toxigenic Corynebacterium diphtheriae var mitis isolated from a child from north west England. Commun Dis Rep CDR Wkly 2002; 12 (4): news. (
24. Titov L, Kolodkina V, Dronina A, Grimont F, Grimont PAD, Lejay-Collin M, et al. Genotypic and phenotypic characteristics of Corynebacterium diphtheriae strains isolated from patients in Belarus during an epidemic period. J Clin Microbiol 2003; 41: 1285-8. (
25. PHLS. Toxigenic Corynebacterium ulcerans in cats. Commun Dis Rep CDR Wkly 2002; 12 (11): news. (
26. Efstratiou A, Engler KH, Dawes CS, Sesardic D. Comparison of phenotypic and genotypic methods for detection of diphtheria toxin among isolates of pathogenic corynebacteria. J Clin Microbiol 1998: 36: 3173-7. (
27. Holmes RK. Biology and molecular epidemiology of diphtheria toxin and the tox gene. J Infect Dis 2000; 181 (Suppl 1): S156-67. (
28. Melnikov V, DeZoysa A, Mazurova I, Kombarova S, Borisova O, Engler KH, et al. Molecular screening for the 'identification' of non-toxigenic tox bearing strains of Corynebacterium diphtheriae from the Russian Federation. In: Programme and abstracts book, Sixth International Meeting of the European Laboratory Working Group on Diphtheria; 2000 21-24 June; Brussels, Belgium. p. 60-1.
29. Oram DM, Avdalovic A, Holmes RK. Construction and characterization of transposon insertion mutations in Corynebacterium diphtheriae that affect expression of the diphtheria toxin repressor (DtxR). J Bacteriol 2002; 184: 5723-32. (


Back to Table of Contents
en es fr

The publisher’s policy on data collection and use of cookies.

Disclaimer: The opinions expressed by authors contributing to Eurosurveillance do not necessarily reflect the opinions of the European Centre for Disease Prevention and Control (ECDC) or the editorial team or the institutions with which the authors are affiliated. Neither ECDC nor any person acting on behalf of ECDC is responsible for the use that might be made of the information in this journal. The information provided on the Eurosurveillance site is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. Our website does not host any form of commercial advertisement. Except where otherwise stated, all manuscripts published after 1 January 2016 will be published under the Creative Commons Attribution (CC BY) licence. You are free to share and adapt the material, but you must give appropriate credit, provide a link to the licence, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.

Eurosurveillance [ISSN] - ©2007-2016. All rights reserved

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.